Broadcasts.com - "Expanding Immunotheapy Benefit in Metastatic RCC" (Journal of Clinical Oncology (JCO) Podcast)

Published: Jan. 11, 2016, 9 p.m.

b'Discussion of a phase I trial of the checkpoint inhibitor atezolizumab in metastatic renal carcinoma.'